1. Potential Survival Benefit of Anti-Apoptosis Protein: Survivin-Derived Peptide Vaccine with and without Interferon Alpha Therapy for Patients with Advanced or Recurrent Urothelial Cancer—Results from Phase I Clinical Trials
   Toshiaki Tanaka et al, 2013, Clinical and Developmental Immunology CrossRef
2. Cancer Immunotherapy – The Target is Precisely on The Cancer and Also Not
   Si Lin Koo et al, 2018, Annals of the Academy of Medicine, Singapore CrossRef
3. Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective study
   Yamin Tan et al, 2017, OncoImmunology CrossRef